Comprehensive Analysis of PIK3CA Mutations and Their Prognostic Implications in Breast Cancer Undergoing Neoadjuvant Therapy

被引：0
|
作者：
Zhao, Jianing [1 ]
Zhang, Huirui [1 ]
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
来源：
LABORATORY INVESTIGATION | 2025年 / 105卷 / 03期
关键词：
D O I：
10.1016/j.labinv.2024.102497
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
273
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancer
    Corso, Giovanni
    Veronesi, Paolo
    Intra, Mattia
    Sacchini, Virgilio
    Galimberti, Viviana
    BIOMARKERS IN MEDICINE, 2017, 11 (07) : 519 - 521
  • [2] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
  • [3] Somatic mutations in the PIK3CA gene and its prognostic implications among Ethiopian breast cancer patients
    Woldesonbet, Zelalem Desalegn
    Yohannes, Meron
    Addissie, Adamu
    Abebe, Tamrat
    Kantelhardt, Eva Johanna
    Vetter, Martina
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [4] Somatic mutations in the PIK3CA gene and its prognostic implications among Ethiopian breast cancer patients
    Woldesonbet, Zelalem Desalegn
    Yohannes, Meron
    Addissie, Adamu
    Abebe, Tamrat
    Kantelhardt, Eva Johanna
    Vetter, Martina
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [5] The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China
    Wu, Haibo
    Wang, Wei
    Du, Jun
    Li, Hong
    Wang, Huogang
    Huang, Liangliang
    Xiang, Hang
    Xie, Jing
    Liu, Xiaoli
    Li, Heng
    Lin, Wenchu
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 1473 - 1492
  • [6] Somatic mutations in the PIK3CA gene and its prognostic implications among Ethiopian Breast cancer patients
    Woldesonbet, Zelalem Desalegn
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [7] PIK3CA mutations and predicting the therapeutic effects of neoadjuvant chemotherapy in primary breast cancer
    Sato, A.
    Tanabe, M.
    Tsuboi, Y.
    Ito, Y.
    Akiyama, F.
    Takahashi, S.
    Murakami, Y.
    Seto, Y.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S72 - S72
  • [8] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    PLOS ONE, 2023, 18 (05):
  • [9] Characterization of PIK3CA mutations in lobular breast cancer
    Desmedt, C.
    Metzger
    Fumagalli, D.
    Brown, D.
    Singhal, S.
    Vincent, D.
    Adnet, P-Y
    Smeets, D.
    Berthed, F.
    Galant, C.
    Salgado, R.
    Veys, I.
    Saini, K.
    Pruneri, G.
    Krop, I.
    Winer, E.
    Michiels, S.
    Piccart, M.
    Lambrechts, D.
    Larsimont, D.
    Viale, G.
    Sotiriou, C.
    CANCER RESEARCH, 2012, 72
  • [10] The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients
    Hayama, Shouko
    Nakamura, Rikiya
    Ishige, Takayuki
    Sangai, Takafumi
    Sakakibara, Masahiro
    Fujimoto, Hiroshi
    Ishigami, Emi
    Masuda, Takahito
    Nakagawa, Ayako
    Teranaka, Ryotaro
    Ota, Satoshi
    Itoga, Sakae
    Yamamoto, Naohito
    Nagashima, Takeshi
    Otsuka, Masayuki
    BMC CANCER, 2023, 23 (01)
12345